undefined undefined
NaN.000
NaN.00%
Soligenix Revenues For Qtr. Ended Mar. 31 Were $100K, EPS $(0.18)
05-10 19:34
PRINCETON, N.J., May 10, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing prod...
05-10 19:30
Soligenix (NASDAQ:SNGX) has priced a public offering of 11.87 million shares of common stock and warrants to purchase up to 11.87 million shares of common stock at a combined public offering price of ...
04-18 20:47
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
04-16 02:11
Gainers: Kaival Brands Innovations Group (KAVL) +200%. Longeveron (LGVN) +45%. Kuke Music Holding Ltd (KUKE) +45%. HUB Cyber Security Ltd. (HUBC) +43%. Soligenix (SNGX) +40%. Snap One Holdings Corp. (...
04-16 00:47
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 38,114.61 while the NASDAQ rose 0.07% to 16,187.02. The S&P 500 also rose, gaining, 0.26% to 5,136.94.
04-16 00:02
Soligenix (SNGX) stock soared 106% in early trading Monday after the company said it received orphan drug designation from the FDA for the active ingredient in its Marburg vaccine, MarVax. The biotech...
04-15 22:13
Soligenix (NASDAQ:SNGX) reported its Q4 earnings results on Friday, March 15, 2...
03-15 21:35
Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024 PRINCETON, N.J., Feb. 8, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage...
02-08 20:30
PRINCETON, N.J., Jan. 25, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing pro...
01-25 20:30